Advertisement

PharmacoEconomics & Outcomes News

, Volume 828, Issue 1, pp 11–11 | Cite as

Counterweight-Plus controls T2DM at low cost

Clinical study
  • 6 Downloads

Reference

  1. Xin Y, et al. Type 2 diabetes remission: economic evaluation of the DiRECT/Counterweight-Plus weight management programme within a primary care randomized controlled trial. Diabetic Medicine : 26 Apr 2019. Available from: URL: http://doi.org/10.1111/dme.13981

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations